Biogen

E3807

Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.

Try in SPARQL Jump to: Surface forms Statements Referenced by

All labels observed (6)

Label Occurrences
Biogen canonical 28
Biogen Idec 2
Avonex 1

Statements (49)

Predicate Object
instanceOf biotechnology company
pharmaceutical company
public company
areaServed worldwide
collaboratesWith Eisai
Ionis Pharmaceuticals
Genentech
surface form: Roche
country United States of America
surface form: United States
focusesOn Alzheimer's disease
amyotrophic lateral sclerosis
multiple sclerosis
neurodegenerative diseases
neurological diseases
spinal muscular atrophy
foundedBy Charles Weissmann
Heinz Schaller
Kenneth Murray
Nils Norman
Phillip A. Sharp
surface form: Phillip Allen Sharp

Walter Gilbert
foundedIn 1978
Geneva
hasKeyTherapeuticArea ALS
Alzheimer's disease
Parkinson's disease
multiple sclerosis
spinal muscular atrophy
hasNotableDrug Spinraza
Tecfidera
Tysabri
hasProduct Aduhelm
Biogen self-linksurface differs
surface form: Avonex

Fampyra
Leqembi
Plegridy
Spinraza
Tecfidera
Tysabri
Vumerity
hasResearchArea immunology
neuroscience
rare diseases
headquartersLocation Cambridge, Massachusetts
industry biotechnology
pharmaceuticals
specializesIn biologic therapies
monoclonal antibodies
small-molecule drugs
tradedAs Biogen self-linksurface differs
surface form: NASDAQ:BIIB

Referenced by (34)

Full triples — surface form annotated when it differs from this entity's canonical label.

Biogen tradedAs Biogen self-linksurface differs
this entity surface form: NASDAQ:BIIB
Biogen hasProduct Biogen self-linksurface differs
this entity surface form: Avonex
Phillip A. Sharp coFounded Biogen
Tecfidera isManufacturedBy Biogen
Leqembi developedBy Biogen
Walter Gilbert coFounderOf Biogen
Plegridy hasManufacturer Biogen
Plegridy hasDeveloper Biogen
Spinraza developedBy Biogen
Spinraza hasBrandOwner Biogen
Tysabri developedBy Biogen
Vumerity developedBy Biogen
Vumerity marketedBy Biogen
Aduhelm developedBy Biogen
Eisai collaboratesWith Biogen
Fampyra developedBy Biogen
this entity surface form: Biogen Idec
Fampyra marketingAuthorisationHolder Biogen
this entity surface form: Biogen Netherlands B.V.
Nils Norman coFounderOf Biogen
Nils Norman alsoKnownAs Biogen
subject surface form: Biogen
this entity surface form: Biogen Inc.
Heinz Schaller coFounded Biogen
Heinz Schaller hasEmployer Biogen
Rituxan developedBy Biogen
Rituxan marketedBy Biogen
Kenneth Murray coFounderOf Biogen
CLARITY AD coSponsor Biogen
Eisai and Biogen collaboratesWith Biogen
subject surface form: Eisai
Elan Pharmaceuticals coDevelopedWith Biogen
this entity surface form: Biogen Idec
EMERGE (Study 302) sponsor Biogen
ENGAGE (Study 301) sponsor Biogen